Union minister, Mansukh Mandaviya, has told representatives of the pharmaceutical industry that Schedule M, which requires adherence to good manufacturing practices, will be mandatory for smaller firms in a phased process. The move follows the minister's call for greater self-regulation amongst the domestic pharma industry, which he said had helped create India's position in quality production.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oRa9OVJ
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Mandaviya asks MSME pharma firms to move towards good manufacturing practices through self regulation
0 comments:
Post a Comment